期刊文献+

卵巢上皮性肿瘤血管生成的研究

Study on Angiogenesis of Epithelial Ovarian Neoplasms
原文传递
导出
摘要 目的 探讨不同性质卵巢上皮性肿瘤的血管生成情况及微血管生成与卵巢癌组织类型、病理分级、临床分期的关系。方法 采用免疫组化SP法。结果 卵巢肿瘤依良性、临界恶性、恶性的不同 ,其微血管密度 (MVD)依次升高。卵巢临界恶性肿瘤组与良性肿瘤组、正常卵巢组MVD均有显著差异 (P <0 0 5 ) ,而卵巢癌组与卵巢临界恶性肿瘤组 ,良性肿瘤与正常卵巢组的MVD无显著差异 (P分别为 0 3 4和 0 46) ,单因素采用生存率时序检验 (Logranktest)结果表明 ,MVD与卵巢癌预后无关 (Log -rankP =0 2 7)。结论 MVD在卵巢发生发展过程中起重要作用 ,可作为判断卵巢肿瘤恶性程度的一项指标 。 Objective To explore the angiogensis in epithelial ovarian neoplasms and the relationship among angiogenesis and clinical stage, the histological type and pathological grade of epithelial ovarian carcinomas. Methods The microvessel density (MVD) was examined in 74 cases of epithelial ovarian neoplasm and 20 nomal samples by using immunohistochemical SP method. Results MVD increased gradually from benign to borderline malignancy and ovarian carcinomas, and MVD there was a significant difference in between the borderline malignancies and benign tumors or normal tissues(P<0 05). But there was no siginificant differences in MVD between the ovarian carcinomas and borderline malignancies or benign tumors and normal samples(P=0 34 and P=0 46,respectively). Log rank test showed that no correlation was found between MVD and survival rate (Log-rank P=0 27). Conclusions Angiogensis may play an important role in pathogenesis and development of ovarian cancer, and MVD can be used as an index to estimate the malignant degree of ovarian neoplasms. MVD could not serve as an index to predict the prognosis of patients with epithelial ovarian cancer.
出处 《中国医师杂志》 CAS 2004年第2期210-211,共2页 Journal of Chinese Physician
关键词 卵巢上皮性肿瘤 血管生成 病理分级 临床分期 免疫组化SP法 Epithelial ovarian neoplasm Angiogenesis MVD Ⅷ related antigen
  • 相关文献

参考文献9

  • 1Emoto M, Iwasaki H, Mimura K, et al. Differences in the angiogenesis of benign and malignant ovarian turmors, demonstrated analysis of color Dopple ultrasound, immunohistochemistry, microvessle density[J]. Cancer, 1997, 80(5): 899-907
  • 2Kerbel RS. Tumor angiogenesis: past, present and the near future[J]. Carcinogenesis,2000,21(3): 505-515
  • 3Orre M, Miri LM, Mamers P, et al. Increased mirrovessle density in mucinous compared with malignant serous and benign tumors of the ovary[J]. Br J Cancer, 1998,77(12): 2204-2209
  • 4Folkman J, Watson K, Zngber D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasm[J]. Nature, 1989,339: 58-61
  • 5Noel Weidner MD, Joseph P, Semple MD, et al. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma[J]. The New England Journal of Medicine, 1991,324(1):1-7
  • 6Darai E, Bringuier AF, Walker CF, et al. CD31 expression in benign, borderline, and malignant epithelial ovarian tumors: An immunohistochemical and serological analysis[J]. Gynecol Oncol, 1998,71(1): 122-127
  • 7Orre M, Rogers PA. Reduced vascular basement-membrane immunostaining in mucinous tumors of the ovary[J]. Int, J cancer, 1998,79(2):139-143
  • 8Shen GH, Ghazizdeh M, Kawanamio, et al. Prognostic significance of VEGF expression in human ovarian carcinoma[J]. Br J Cancer, 2000,83(2): 196-203
  • 9Obermair A, Wasicky R, Kaider A, et al. Prognostic significance of tumor angiogenesis in epithelial ovarian cancer[J]. Cancer Lett 1999,138(1-2):175-182

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部